Skip to content

Medical Marijuana Use in HIV+ Patients Prospective Cohort Study

Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients Prospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01536899
Acronym
MMC-1
Enrollment
119
Registered
2012-02-22
Start date
2012-02-29
Completion date
2017-06-30
Last updated
2018-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Positive, Marijuana Smoking

Keywords

HIV positive, Medical Marijuana

Brief summary

The investigators are interested in understanding personal factors such as medical conditions and mental health, as well as social and economic factors, that influence marijuana (and other substance) use in HIV-positive patients. Several alternative hypotheses will be evaluated in the proposed project: 1. healthier patients may self-select marijuana use; 2. marijuana use may be associated with consequences that create barriers to seeking healthcare; 3. marijuana use may have medicinal value that reduces the need for such care.

Detailed description

The study will involve a total of 5 interviews with clinical research staff members, the total involvement will be for about 1 year. The first interview will establish a baseline of current behaviors and health status; this will take about 3-4 hours. This interview will take place at the Tolan Park Medical Building, located at 3901 Chrysler Service Dr. The remaining 4 interviews - which will be shorter in length - will be conducted about 3, 6, 9, and 12 months after the baseline interview; each follow-up interview will take about 2 hours.The purpose of the 4 remaining interviews is to assess changes in behaviors and health status over time. We will collect urine samples at each of the 5 interview sessions to assess health and illicit drug use.

Interventions

None listed

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Wayne State University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Participants will be patients in the HIV clinic. * Participants will have HIV. * Participants will sign a single consent form. * Participants will be marijuana users.

Exclusion criteria

* Participants who test negative for marijuana will be excluded. * Volunteers who exhibit signs of drug intoxication or cognitive/mental impairment during the consent process will be excluded.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 3, 2026